Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Choy

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Current Rheumatology Reports|August 9, 2024
How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?Sharmila Khot, George Tackley, Ernest Choy
International Journal of Molecular Sciences|January 21, 2023
The Beneficial Effects of Pine Nuts and Its Major Fatty Acid, Pinolenic Acid, on Inflammation and Metabolic Perturbations in Inflammatory DisordersRabaa Takala, Dipak P Ramji, Ernest Choy
Current Medical Research and Opinion|September 18, 2012
Variation in the use of biologics in the management of rheumatoid arthritis across the UKErnest Choy, Peter Taylor, Sandra McAuliffe, et al.
Rheumatology Advances in Practice|December 19, 2024
The pattern of anti-IL-6 versus non-anti-IL-6 biologic disease modifying anti-rheumatic drugs use in patients with rheumatoid arthritis in Wales, UK: a real-world study using electronic health recordsRoxanne Cooksey, Jonathan Kennedy, Muhammad Rahman, et al.
Autoimmunity Reviews|August 27, 2023
Start RA treatment - Biologics or JAK-inhibitors?Roberto Caporali, Sabino Germinario, Dorottya Kacsándi, et al.
Rheumatology Advances in Practice|August 1, 2022
Real-world use of an etanercept biosimilar including selective <i>versus</i> automatic substitution in inflammatory arthritis patients: a UK-based electronic health records studyRoxanne Cooksey, Sinead Brophy, Jonathan Kennedy, et al.
BMC Health Services Research|October 12, 2012
Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgiaSerge Perrot, Ernest Choy, Danielle Petersel, et al.
Rheumatology (Oxford, England)|June 8, 2014
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentErnest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, et al.
Rheumatology Advances in Practice|October 11, 2021
Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UKRoxanne Cooksey, Muhammad Azizur Rahman, Jonathan Kennedy, et al.
Drug Safety|January 11, 2018
The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature ReviewMichael Nurmohamed, Ernest Choy, Sadiq Lula, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Current Rheumatology Reports|August 9, 2024
How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?Sharmila Khot, George Tackley, Ernest Choy
International Journal of Molecular Sciences|January 21, 2023
The Beneficial Effects of Pine Nuts and Its Major Fatty Acid, Pinolenic Acid, on Inflammation and Metabolic Perturbations in Inflammatory DisordersRabaa Takala, Dipak P Ramji, Ernest Choy
Current Medical Research and Opinion|September 18, 2012
Variation in the use of biologics in the management of rheumatoid arthritis across the UKErnest Choy, Peter Taylor, Sandra McAuliffe, et al.
Rheumatology Advances in Practice|December 19, 2024
The pattern of anti-IL-6 versus non-anti-IL-6 biologic disease modifying anti-rheumatic drugs use in patients with rheumatoid arthritis in Wales, UK: a real-world study using electronic health recordsRoxanne Cooksey, Jonathan Kennedy, Muhammad Rahman, et al.
Autoimmunity Reviews|August 27, 2023
Start RA treatment - Biologics or JAK-inhibitors?Roberto Caporali, Sabino Germinario, Dorottya Kacsándi, et al.
Rheumatology Advances in Practice|August 1, 2022
Real-world use of an etanercept biosimilar including selective <i>versus</i> automatic substitution in inflammatory arthritis patients: a UK-based electronic health records studyRoxanne Cooksey, Sinead Brophy, Jonathan Kennedy, et al.
BMC Health Services Research|October 12, 2012
Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgiaSerge Perrot, Ernest Choy, Danielle Petersel, et al.
Rheumatology (Oxford, England)|June 8, 2014
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentErnest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, et al.
Rheumatology Advances in Practice|October 11, 2021
Biologic use in psoriatic arthritis and ankylosing spondylitis patients: a descriptive epidemiological study using linked, routine data in Wales, UKRoxanne Cooksey, Muhammad Azizur Rahman, Jonathan Kennedy, et al.
Drug Safety|January 11, 2018
The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature ReviewMichael Nurmohamed, Ernest Choy, Sadiq Lula, et al.
Pageof 17